Association of cardiovascular-kidney-metabolic syndrome with cardiovascular, cancer, and all-cause mortality among US adults: A prospective study

J Formos Med Assoc. 2026 Apr 3:S0929-6646(26)00331-1. doi: 10.1016/j.jfma.2026.03.148. Online ahead of print.ABSTRACTAIMS: Cardiovascular-kidney-metabolic (CKM) syndrome, comprising chronic kidney disease, cardiovascular disease (CVD), and metabolic syndrome, poses a significant threat to global pub

C Cheng Zhang

Guideline-based lipid-lowering therapy in acute coronary syndromes: A simulation of population-level impact on cardiovascular events and LDL-C goal achievement

J Clin Lipidol. 2026 Mar 14:S1933-2874(26)00074-7. doi: 10.1016/j.jacl.2026.03.007. Online ahead of print.ABSTRACTBACKGROUND: Despite high cardiovascular risk, many patients with acute coronary syndrome (ACS) do not receive timely intensification of lipid-lowering therapy (LLT).OBJECTIVE: To predict

D Dylan L Steen

Association of LDL-C between parents and younger offspring: A cross-sectional study using the Korea National Health and Nutrition Examination Survey

J Clin Lipidol. 2026 Mar 15:S1933-2874(26)00073-5. doi: 10.1016/j.jacl.2026.03.009. Online ahead of print.ABSTRACTBACKGROUND: Atherosclerotic cardiovascular disease develops in adulthood, but its metabolic precursors, such as dyslipidemia, often emerge during childhood.OBJECTIVE: This study aimed to

H Hee Yeon Kay

The effect of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on the lipid profiles of patients with type II diabetes and coronary artery disease: A retrospective study

J Clin Lipidol. 2026 Mar 16:S1933-2874(26)00070-X. doi: 10.1016/j.jacl.2026.03.010. Online ahead of print.ABSTRACTBACKGROUND: Patients with type 2 diabetes mellitus and established coronary artery disease (CAD) carry a very high cardiovascular risk, requiring aggressive lipid management. Sodium-gluc

A Anish Theertham

Global burden of aortic aneurysm attributed to high systolic blood pressure from 1990 to 2021: a systematic analysis of the global burden of disease study

Nutr Metab Cardiovasc Dis. 2026 Feb 26:104642. doi: 10.1016/j.numecd.2026.104642. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Aortic aneurysm (AA) is a significant cardiovascular condition with high mortality and disability burdens. High systolic blood pressure (SBP) is a major modifiable ris

H Hao Liu

Subclinical carotid atherosclerosis in latent autoimmune diabetes in adults and type 2 diabetes mellitus: a cross-sectional study

Nutr Metab Cardiovasc Dis. 2026 Mar 4:104675. doi: 10.1016/j.numecd.2026.104675. Online ahead of print.ABSTRACTBACKGROUND AND AIM: Despite differing clinical phenotypes, the cardiovascular-metabolic risks and complications of latent autoimmune diabetes in adults (LADA) versus type 2 diabetes mellitu

T Tiantian Cai

Serum uric acid as a reflection of residual risk in statin-treated patients with cardiovascular disease: Insights from NHANES 1999-2018

Nutr Metab Cardiovasc Dis. 2026 Feb 11:104603. doi: 10.1016/j.numecd.2026.104603. Online ahead of print.ABSTRACTBACKGROUND AND AIM: Serum uric acid (SUA) is associated with cardiovascular disease (CVD) prognosis, and statins may modulate SUA levels. The purpose of this study is to investigate the pr

Z Zhe Zhang

Metabolite clusters linking fatty liver disease to cardiovascular mortality in coronary heart disease patients

Nutr Metab Cardiovasc Dis. 2025 Dec 24:104535. doi: 10.1016/j.numecd.2025.104535. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: We aimed to identify metabolite clusters and assess their relationships with prevalent steatotic liver disease (SLD) and fatal cardiovascular diseases (CVD) risk in co

L Luc Heerkens

Dietary antioxidants and cardiometabolic health in the Ardabil Persian cohort

Nutr Metab Cardiovasc Dis. 2026 Mar 2:104665. doi: 10.1016/j.numecd.2026.104665. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Cardiovascular diseases (CVDs) remain a major global health burden, with oxidative stress and inflammation playing key roles in their development. This study investigat

M Mahsa Mohajeri

Trends and Disparities in Aortic Stenosis and Coronary Artery Disease-Related Mortality Among U.S. Adults Aged 65 Years, 1999-2024

Ann Vasc Surg. 2026 Apr 2:S0890-5096(26)00221-9. doi: 10.1016/j.avsg.2026.03.051. Online ahead of print.ABSTRACTINTRODUCTION: Aortic stenosis (AS) and coronary artery disease (CAD) frequently coexist in older adults due to shared risk factors and overlapping pathophysiologic mechanisms. Despite subs

S Shaikh Muhammad Daniyal

Key Role of the Pharmacist in Collaboration with General Practitioners and Nephrologists in the Management of Chronic Kidney Disease

Ann Pharm Fr. 2026 Apr 2:S0003-4509(26)00042-8. doi: 10.1016/j.pharma.2026.03.004. Online ahead of print.ABSTRACTChronic kidney disease (CKD) is a major public health issue, affecting nearly 10% of the adult population, with a significant proportion of diagnoses occurring at advanced stages, often r

S Sophie Liabeuf

Impella Protected Percutaneous Coronary Intervention Outcomes Compared with Intra-Aortic Balloon Pump: A Contemporary View

Am J Cardiol. 2026 Apr 2:S0002-9149(26)00203-1. doi: 10.1016/j.amjcard.2026.03.060. Online ahead of print.ABSTRACTTraditional cardiovascular trials combine adverse events into composites, ignoring the clinical importance and weight of endpoints. The Win Ratio ("WR") is a contemporary statistical tec

V Vasileios Panoulas

Risk factors for Klebsiella spp. infection after solid organ transplantation: a multi-center, case-control study

J Hosp Infect. 2026 Apr 2:S0195-6701(26)00120-9. doi: 10.1016/j.jhin.2026.03.030. Online ahead of print.ABSTRACTBACKGROUND: Klebsiella spp. are a major cause of antimicrobial-resistant hospital-acquired infections. We aimed to identify possible risk factors for Klebsiella infection during 180 days a

A Argyro Ftergioti

Nonlinear and Episodic Growth in the Natural History of Ascending Aortic Dilation

Can J Cardiol. 2026 Apr 2:S0828-282X(26)00284-9. doi: 10.1016/j.cjca.2026.03.035. Online ahead of print.ABSTRACTBACKGROUND: Predicting ascending aortic (AsAo) growth is challenging. Linear, continuous assumptions may oversimplify biology. We evaluated: (1) whether baseline body size-indexed diameter

C Carlos Alberto Campello Jorge

Genetic variation at the MECOM locus shaping human disease pathogenesis

Pharmacol Ther. 2026 Apr 2:109027. doi: 10.1016/j.pharmthera.2026.109027. Online ahead of print.ABSTRACTThe gene MDS1 and EVI1 complex locus (MECOM) functions as a transcriptional regulator essential for development. Variants in MECOM have been recognized as pathogenic drivers, with well-established

J Jiayi Chen

Implanted Electronic Device Management in a Pencil-Beam Scanning Proton-Therapy Clinic

Pract Radiat Oncol. 2026 Apr 2:S1879-8500(26)00102-5. doi: 10.1016/j.prro.2026.03.004. Online ahead of print.ABSTRACTPURPOSE: Present single-institution workflows and experience for treating patients with implanted electronic devices (IEDs) at a high-volume proton pencil-beam scanning clinic.METHODS

M Mark D Pepin

Clinical engagement and cardiovascular outcomes of screening-detected atrial fibrillation in working-age adults

No abstractJ Cardiol. 2026 Apr 2:S0914-5087(26)00070-5. doi: 10.1016/j.jjcc.2026.03.014. Online ahead of print.NO ABSTRACTPMID:41935681 | DOI:10.1016/j.jjcc.2026.03.014

Y Yuichiro Mori

Absent nocturnal cortisol decline in Pheochromocytoma: A retrospective study

Steroids. 2026 Apr 2:109779. doi: 10.1016/j.steroids.2026.109779. Online ahead of print.ABSTRACTPheochromocytoma is a catecholamine-producing tumor that may exhibit atypical hormonal profiles. Emerging evidence suggests an association with cortisol dysregulation in the absence of overt Cushing syndr

Y Yahan Sun

Exposure to OBS induces endothelial dysfunction via miRNA-mRNA regulatory networks: implications for cardiovascular disease risk

Comp Biochem Physiol C Toxicol Pharmacol. 2026 Apr 2:110534. doi: 10.1016/j.cbpc.2026.110534. Online ahead of print.ABSTRACTSodium p-perfluorous nonenoxybenzenesulfonate (OBS), an emerging alternative to perfluorooctane sulfonate (PFOS), has raised public health concerns due to its potential cardiov

B Boxiang Zhang

Auricular Nodule in 53-Year-Old Man with Subclinical Coronary Artery Disease

No abstractAm J Med. 2026 Apr 2:S0002-9343(26)00268-8. doi: 10.1016/j.amjmed.2026.03.047. Online ahead of print.NO ABSTRACTPMID:41935661 | DOI:10.1016/j.amjmed.2026.03.047

N Niloufar Javadi

Human APOB mice translates molecular phenotypes across the Alzheimer's disease spectrum

Brain Behav Immun. 2026 Apr 2:106575. doi: 10.1016/j.bbi.2026.106575. Online ahead of print.ABSTRACTBACKGROUND: Apolipoprotein B (APOB), a structural component of low-density lipoproteins (LDL), has historically been associated with peripheral lipid transport and cardiovascular disease. Recent studi

G Gabriel Aumont-Rodrigue

Subclinical atherosclerosis in inflammatory bowel disease: Prevalence, vascular distribution and implications for cardiovascular risk stratification

Gastroenterol Hepatol. 2026 Apr 2:502755. doi: 10.1016/j.gastrohep.2026.502755. Online ahead of print.ABSTRACTOBJECTIVE: Cardiovascular (CV) risk assessment in patients with inflammatory bowel disease (IBD) remains insufficiently explored. This study aimed to assess the role of vascular Doppler ultr

G Gonzalo Fernández Villar

Rationale and design of the Corrie Lipids Program: Impact of a digital health-enabled implementation initiative to improve lipid management

Am Heart J. 2026 Apr 2:107440. doi: 10.1016/j.ahj.2026.107440. Online ahead of print.ABSTRACTRATIONALE: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality worldwide. Lowering low-density lipoprotein cholesterol (LDL-C) with statins and non-statin therapies

A Allison W Peng

Cardiorenal outcomes of empagliflozin versus dapagliflozin in primary prevention among patients with type 2 diabetes: A nationwide cohort study

Diabetes Res Clin Pract. 2026 Apr 2:113239. doi: 10.1016/j.diabres.2026.113239. Online ahead of print.ABSTRACTAIMS: While both empagliflozin and dapagliflozin have demonstrated cardiorenal benefits in patients with type 2 diabetes, their comparative effectiveness in patients without established card

S Sangwoo Park